Nar inhibited the proliferation of breast cancer (MCF-7) cells by blocking insulin stimulated glucose uptake in GLUT4 (insulin responsive glucose transporter) expressing, insulin responsive MCF-7 cells. The gene discussed is INS; the disease is breast cancer.